The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease

NACompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

July 4, 2022

Primary Completion Date

August 17, 2023

Study Completion Date

March 29, 2024

Conditions
Intracranial Arterial DiseasesStent RestenosisPercutaneous Transluminal Angioplasty
Interventions
DEVICE

Self-expanding intracranial drug stent system

All patients receive Percutaneous transluminal angioplasty and stenting with self-expanding intracranial drug stent system (Temporary abbreviations: SINOMED IS-DES)

Trial Locations (14)

Unknown

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

The First Hospital of Jilin University, Changchun

The First People's Hospital of Changzhou, Changzhou

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

Hangzhou First people's Hospital, Zhejiang University School of Medicine, Hangzhou

The First Affiliated Hospital of Harbin Medical University, Ha’erbin

The First Affiliated Hospital of USTC Anhui provincial hospital, Hefei

Qilu Hospital, Shandong University, Jinan

The Affiliated Hospital of Qingdao University, Qingdao

Changhai Hospital, Shanghai

Shanghai Fourth People's Hospital, Shanghai

The First Hospital of Hebei Medical University, Shijiazhuang

Yantai Yu Huang Ding hospital, Yantai

The First Affiliated hospital of Zhengzhou hospital, Zhengzhou

All Listed Sponsors
collaborator

Changhai Hospital

OTHER

lead

Sinomed Neurovita Technology Inc.

INDUSTRY